secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001425450-25-000092
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q2 revenue hits record $61.1M (+16% YoY); raises FY2025 guidance
--------------------------------------------------------------------------------

- Revenue of $61.1M (+16% YoY); domestic up 17%, international up 12%.
- Adjusted EBITDA $4.1M (+58% YoY); non-GAAP EPS improved to ($0.11) from ($0.23).
- Raised FY2025 revenue guidance to $237-242M from $236-242M; reaffirmed adjusted EBITDA $15-17M.
- Scoliosis revenue +35% to $18.5M; Trauma & Deformity +10% to $41.7M.
- OPSB expanded with new clinics, entry into Ireland for first international operation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545025000092/0001425450-25-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545025000092/kids-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001425450-25-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer